FR2486529B1 - - Google Patents

Info

Publication number
FR2486529B1
FR2486529B1 FR8113607A FR8113607A FR2486529B1 FR 2486529 B1 FR2486529 B1 FR 2486529B1 FR 8113607 A FR8113607 A FR 8113607A FR 8113607 A FR8113607 A FR 8113607A FR 2486529 B1 FR2486529 B1 FR 2486529B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8113607A
Other versions
FR2486529A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of FR2486529A1 publication Critical patent/FR2486529A1/fr
Application granted granted Critical
Publication of FR2486529B1 publication Critical patent/FR2486529B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J3/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J33/00Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/002Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J3/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR8113607A 1980-07-10 1981-07-10 Steroides doux anti-inflammatoires et medicament contenant ces substances Granted FR2486529A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16845380A 1980-07-10 1980-07-10
US26578581A 1981-05-21 1981-05-21

Publications (2)

Publication Number Publication Date
FR2486529A1 FR2486529A1 (fr) 1982-01-15
FR2486529B1 true FR2486529B1 (fr) 1985-01-04

Family

ID=26864131

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8113607A Granted FR2486529A1 (fr) 1980-07-10 1981-07-10 Steroides doux anti-inflammatoires et medicament contenant ces substances

Country Status (17)

Country Link
KR (2) KR860000266B1 (fr)
AT (1) AT379816B (fr)
AU (1) AU540898B2 (fr)
CA (1) CA1174667A (fr)
CH (1) CH648856A5 (fr)
DE (1) DE3126732A1 (fr)
DK (1) DK165837C (fr)
ES (2) ES8300785A1 (fr)
FI (1) FI71748C (fr)
FR (1) FR2486529A1 (fr)
GB (1) GB2079755B (fr)
IT (1) IT1205446B (fr)
NL (1) NL192343C (fr)
NO (1) NO163285C (fr)
PH (1) PH25874A (fr)
PT (1) PT73348B (fr)
SE (1) SE449106B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2137206B (en) * 1980-02-15 1985-04-03 Glaxo Group Ltd Androstane 17-carbothioc acid derivatives
JPS6041607A (ja) * 1983-08-12 1985-03-05 Otsuka Pharmaceut Co Ltd 軟膏基剤
SE8501693D0 (sv) * 1985-04-04 1985-04-04 Draco Ab Novel 16,17-acetalsubstituted androstane-17beta-carboxylic acid esters
IL78144A0 (en) * 1985-04-04 1986-07-31 Draco Ab Novel androstane-17beta-carboxylic acid esters
WO1989003390A1 (fr) * 1987-10-13 1989-04-20 Bodor Nicholas S Steroides legers ayant une activite anti-inflammatoire
DE4025342A1 (de) * 1990-08-10 1992-02-13 Hoechst Ag In 17-stellung substituierte corticoid-17-alkylcarbonate, verfahren zu deren herstellung und diese enthaltende arzneimittel
WO1999001467A2 (fr) * 1997-06-30 1999-01-14 Glaxo Group Limited Composes
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
EP2067784A3 (fr) 2000-08-05 2012-08-22 Glaxo Group Limited Dérivés de 17.béta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane utilisés comme anti-inflammatoires
US6787532B2 (en) 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
GB0316290D0 (en) 2003-07-11 2003-08-13 Glaxo Group Ltd Novel compounds
ATE517908T1 (de) 2005-01-10 2011-08-15 Glaxo Group Ltd Androstan-17-alpha-carbonat-derivate zur verwendung bei der behandlung allergischer und entzündlicher zustände
TWI374147B (en) * 2006-01-27 2012-10-11 Sun Pharma Advance Res Company Ltd Novel 11β-hydroxyandrosta-4-ene-3-ones
US7691811B2 (en) * 2006-05-25 2010-04-06 Bodor Nicholas S Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye
US7687484B2 (en) * 2006-05-25 2010-03-30 Bodor Nicholas S Transporter enhanced corticosteroid activity
CN101942001B (zh) * 2010-08-24 2013-02-06 山东省医药工业研究所 一种氯替泼诺的提纯方法
CN103183714A (zh) * 2011-12-29 2013-07-03 山东方明药业集团股份有限公司 一种氯替泼诺的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1384372A (en) * 1971-01-20 1975-02-19 Glaxo Lab Ltd Dereivatives of 17alpha-hydroxyandrost-4-ene-17beta-carboxylic acids
GB1438940A (en) * 1972-07-19 1976-06-09 Glaxo Lab Ltd 17beta-haloalkoxycarbonyl-17alpha-oxysteroids
GB1514476A (en) * 1974-08-30 1978-06-14 Glaxo Lab Ltd Alkyl and haloalkyl androst-4-ene and androsta-1,4-diene-17beta-carboxylates
DE2735110A1 (de) * 1977-08-04 1979-02-15 Hoechst Ag Corticoid-17-alkylcarbonate und verfahren zu ihrer herstellung
IT1114534B (it) * 1978-02-08 1986-01-27 Glaxo Group Ltd Steroide anti-infiammatorio della serie dell'androstano composizioni che lo contengono e procedimento per produrlo
US4188385A (en) * 1978-04-05 1980-02-12 Syntex (U.S.A.) Inc. Thioetianic acid derivatives
DE2817988A1 (de) * 1978-04-25 1979-11-08 Hoechst Ag Corticoid 17-alkylcarbonate und verfahren zu deren herstellung

Also Published As

Publication number Publication date
KR860000266B1 (ko) 1986-03-22
DK302181A (da) 1982-01-11
AT379816B (de) 1986-03-10
AU7259181A (en) 1982-01-14
GB2079755B (en) 1985-01-30
FR2486529A1 (fr) 1982-01-15
GB2079755A (en) 1982-01-27
DE3126732C2 (fr) 1987-04-30
ES8306767A1 (es) 1983-06-16
SE449106B (sv) 1987-04-06
PT73348A (en) 1981-08-01
DK165837C (da) 1993-06-21
ES504340A0 (es) 1982-12-01
NL192343C (nl) 1997-06-04
IT1205446B (it) 1989-03-23
NO812344L (no) 1982-01-11
SE8104132L (sv) 1982-01-11
KR830006327A (ko) 1983-09-24
NO163285B (no) 1990-01-22
NL192343B (nl) 1997-02-03
FI71748B (fi) 1986-10-31
NO163285C (no) 1990-05-02
ATA307081A (de) 1985-07-15
AU540898B2 (en) 1984-12-06
ES8300785A1 (es) 1982-12-01
FI71748C (fi) 1987-02-09
NL8103315A (nl) 1982-02-01
IT8105186A0 (it) 1981-07-09
KR860000452B1 (ko) 1986-04-26
PH25874A (en) 1991-12-02
FI812175L (fi) 1982-01-11
ES514633A0 (es) 1983-06-16
PT73348B (en) 1982-09-23
KR850002759A (ko) 1985-05-15
DK165837B (da) 1993-01-25
CH648856A5 (de) 1985-04-15
CA1174667A (fr) 1984-09-18
DE3126732A1 (de) 1982-03-25

Similar Documents

Publication Publication Date Title
FR2474982B1 (fr)
FR2475050B1 (fr)
FR2473185B1 (fr)
DE3120443C2 (fr)
FR2486529B1 (fr)
DE3123914C2 (fr)
FR2474004B3 (fr)
FR2472918B1 (fr)
FR2474171B1 (fr)
FR2474756B3 (fr)
DE3127197C2 (fr)
DE3150296C2 (fr)
FR2474244B1 (fr)
FR2474589B1 (fr)
DE3119763C2 (fr)
FR2474156B3 (fr)
FR2475266B1 (fr)
FR2474867B1 (fr)
DE3001906C2 (fr)
DE3129004C2 (fr)
FR2473403B1 (fr)
FR2474797B1 (fr)
FR2474317B1 (fr)
DE3150416C2 (fr)
JPS5749444U (fr)

Legal Events

Date Code Title Description
TP Transmission of property